ALLISON SENERCHIA: Open Payments
NPI 1952733958 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,018 in 39 payments from 14 companies in 2025. Trend: 2023 $0 · 2024 $69 · 2025 $1,018
Food & beverage: $1,018
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 7 | $246 |
| GENZYME CORPORATION | 7 | $170 |
| Incyte Corporation | 9 | $138 |
| E.R. Squibb & Sons, L.L.C. | 1 | $80 |
| Janssen Biotech, Inc. | 3 | $77 |
| Lilly USA, LLC | 2 | $62 |
| UCB, Inc. | 2 | $55 |
| Regeneron Healthcare Solutions, Inc. | 1 | $39 |
| Organon LLC | 2 | $38 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 1 | $37 |
Products named: DUPIXENT, SKYRIZI, OPZELURA, Sotyktu, TREMFYA, Bimzelx, RINVOQ, BLU-U.
Industry payments across DC — which companies pay providers there.
